{"altmetric_id":21249196,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":3},"news":{"unique_users_count":1,"unique_users":["medicalxpress"],"posts_count":1},"twitter":{"unique_users_count":2,"unique_users":["CancerCureNow","TrueDiagnostics"],"posts_count":2}},"selected_quotes":["Inhibition of CDK4\/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mous"],"citation":{"abstract":"\u00a0 <p>Bioinformatics analysis followed by in vivo studies in patient-derived xenograft models were used to identify and validate CDK 4\/6 inhibition as an effective therapeutic strategy for medulloblastoma, particularly Group 3 MYC-amplified tumors which have the worst clinical prognosis.<\/p> <br \/>Experimental Design: <p>A protein interaction network derived from a Sleeping Beauty mutagenesis model of medulloblastoma was used to identify potential novel therapeutic targets.\u00a0 The top hit from this analysis was validated in vivo using patient-derived xenograft models of medulloblastoma implanted subcutaneously in the flank and orthotopically in the cerebellum of mice.<\/p> <br \/>Results: <p>Informatics analysis identified the CDK4\/6\/CYCLIN D\/RB pathway as a novel \"druggable\" pathway for multiple subgroups of medulloblastoma.\u00a0 Palbociclib, a highly specific inhibitor of CDK4\/6, was found to inhibit RB phosphorylation and cause G1 arrest in patient-derived xenograft (PDX) models of medulloblastoma.\u00a0 The drug caused rapid regression of Sonic hedgehog (SHH) and MYC-amplified Group 3 medulloblastoma subcutaneous tumors and provided a highly significant survival advantage to mice bearing MYC-amplified intracranial tumors.\u00a0<\/p> <br \/>Conclusions:<br \/>Inhibition of CDK4\/6 is potentially a highly effective strategy for the treatment of SHH and MYC-amplified Group 3 medulloblastoma.","altmetric_jid":"4f6fa6113cf058f610006efa","authors":["Michelle L Cook Sangar","Laura A Genovesi","Madison W Nakamoto","Melissa J Davis","Sue E Knoblaugh","Pengxiang Ji","Amanda Millar","Brandon Wainwright","James M Olson","Michelle L. Cook Sangar","Laura A. Genovesi","Madison W. Nakamoto","Melissa J. Davis","Sue E. Knobluagh","Brandon J. Wainwright","James M. Olson"],"doi":"10.1158\/1078-0432.ccr-16-2943","first_seen_on":"2017-06-21T22:32:58+00:00","funders":["niehs"],"handles":[],"issns":["1557-3265","1078-0432"],"journal":"Clinical Cancer Research","last_mentioned_on":1506920412,"links":["http:\/\/clincancerres.aacrjournals.org\/content\/early\/2017\/06\/21\/1078-0432.CCR-16-2943?papetoc=","http:\/\/dx.doi.org\/10.1158\/1078-0432.CCR-16-2943","http:\/\/clincancerres.aacrjournals.org\/content\/23\/19\/5802?rss=1"],"pdf_url":"http:\/\/clincancerres.aacrjournals.org\/content\/clincanres\/early\/2017\/06\/21\/1078-0432.CCR-16-2943.full.pdf","pmid":"28637687","pubdate":"2017-01-01T00:00:00+00:00","publisher":"American Association for Cancer Research","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Inhibition of CDK4\/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/inhibition-cdk46-palbociclib-significantly-extends-survival-medulloblastoma-patientderived-xenograft"},"altmetric_score":{"score":10.25,"score_history":{"1y":10.25,"6m":10.25,"3m":10,"1m":1,"1w":1,"6d":1,"5d":1,"4d":1,"3d":1,"2d":1,"1d":1,"at":10.25},"context_for_score":{"all":{"total_number_of_other_articles":8457786,"mean":7.1057941851127,"rank":850928,"this_scored_higher_than_pct":89,"this_scored_higher_than":7599101,"rank_type":"exact","sample_size":8457786,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":240332,"mean":12.969421256517,"rank":38339,"this_scored_higher_than_pct":83,"this_scored_higher_than":201734,"rank_type":"exact","sample_size":240332,"percentile":83},"this_journal":{"total_number_of_other_articles":5504,"mean":6.3195031800836,"rank":568,"this_scored_higher_than_pct":89,"this_scored_higher_than":4934,"rank_type":"exact","sample_size":5504,"percentile":89},"similar_age_this_journal_3m":{"total_number_of_other_articles":78,"mean":8.6406233766234,"rank":15,"this_scored_higher_than_pct":80,"this_scored_higher_than":63,"rank_type":"exact","sample_size":78,"percentile":80}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Student  > Ph. D. Student":1},"by_discipline":{"Engineering":1}}},"geo":{"twitter":{"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/CancerCureNow\/statuses\/877655557443788800","license":"gnip","citation_ids":[21249196],"posted_on":"2017-06-21T22:32:45+00:00","author":{"name":"Cure Cancer Now","url":"http:\/\/cancercure-d.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1128872809\/Hep_G2_Lab_test_normal.jpg","description":"Pure science is what it is taking to defeat cancer. Follow us to be a part of history in the making. Receive only the best information here.","id_on_source":"CancerCureNow","tweeter_id":"193691326","geo":{"lt":null,"ln":null},"followers":8362},"tweet_id":"877655557443788800"},{"url":"http:\/\/twitter.com\/TrueDiagnostics\/statuses\/914716626204942336","license":"gnip","citation_ids":[21249196],"posted_on":"2017-10-02T05:00:12+00:00","author":{"name":"Jerry Lee","url":"http:\/\/www.truediag.com","image":"https:\/\/pbs.twimg.com\/profile_images\/567483990097936384\/6uKJglvi_normal.jpeg","description":"We specialize in providing quick & simple quantitative test systems designed for point-of-care monitoring. Test results in minutes not days..","id_on_source":"TrueDiagnostics","tweeter_id":"317232537","geo":{"lt":32.71533,"ln":-117.15726,"country":"US"},"followers":377},"tweet_id":"914716626204942336"}],"news":[{"title":"Potential treatment for brain cancer as drug shrinks tumours","url":"http:\/\/ct.moreover.com\/?a=31514004293&p=1pl&v=1&x=TcwelemleBcfmXc5N1kh7w","license":"public","citation_ids":[21249196],"posted_on":"2017-08-14T11:20:03+00:00","summary":"An international team of researchers has found a drug previously approved to treat breast cancer could also be used to shrink medulloblastoma, a common form of childhood brain tumour.","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}}]}}